Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2026)

Ginkgo Bioworks Holdings has reported Gross Profit for 7 years, with the latest figure at $16.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 52.03% year-over-year to $16.4 million; the trailing twelve-month figure through Mar 2026 stood at $150.2 million (down 38.01% YoY), and the FY2025 full-year result was $170.2 million, down 25.06% from the prior year.
• Gross Profit for Q1 2026 stood at $16.4 million, down from $59.0 million in the prior quarter.
• The five-year high for Gross Profit was $82.1 million in Q4 2023, with the low at -$91.7 million in Q2 2023.
• Historically, Gross Profit has averaged $23.6 million across 5 years, with a median of $34.1 million in 2025.
• Annual changes were most pronounced in 2022 — Gross Profit slumped 622.68% — and 2023, when it soared 15212.15%.
• Ginkgo Bioworks Holdings' Gross Profit stood at $550000.0 in 2022, then surged by 14836.18% to $82.1 million in 2023, then dropped by 8.89% to $74.8 million in 2024, then dropped by 21.21% to $59.0 million in 2025, then slumped by 72.23% to $16.4 million in 2026.
• The last three Gross Profit figures came in at $16.4 million (Q1 2026), $59.0 million (Q4 2025), and $30.7 million (Q3 2025), per Business Quant data.